These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3691608)

  • 1. Predictability of serum concentrations of aminoglycosides after haemodialysis.
    Dijkmans BA; Mattie H
    Eur J Clin Pharmacol; 1987; 33(2):179-83. PubMed ID: 3691608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin and tobramycin Kinetics.
    Counts GW; Blair AD; Wagner KF; Turck M
    Clin Pharmacol Ther; 1982 May; 31(5):662-8. PubMed ID: 7075115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
    Dzierzanowska D; Nowik-Jurek M; Podleśny J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous arteriovenous hemofiltration of aminoglycoside antibiotics in critically ill patients.
    Zarowitz BJ; Anandan JV; Dumler F; Jayashankar J; Levin N
    J Clin Pharmacol; 1986; 26(8):686-9. PubMed ID: 3793961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.
    Mayhew JW; Gorbach SL
    Antimicrob Agents Chemother; 1978 Dec; 14(6):851-55. PubMed ID: 369455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical assay, involving liquid chromatography, for aminoglycoside antibiotics in serum.
    Bäck SE; Nilsson-Ehle I; Nilsson-Ehle P
    Clin Chem; 1979 Jul; 25(7):1222-5. PubMed ID: 455641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.
    Christopher TG; Blair AD; Forrey AW; Cutler RE
    J Pharmacokinet Biopharm; 1976 Oct; 4(5):427-41. PubMed ID: 1003328
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum aminoglycoside monitoring by enzyme immunoassay, biological, and fluorescence immunoassay procedures.
    Buchanan AG; Witwicki E; Albritton WL
    Am J Med Technol; 1983 Jun; 49(6):437-41. PubMed ID: 6349357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations.
    Franck B; Monchaud C; Saint-Marcoux F; Rérolle JP; Allard J; Allot V; Marquet P; Essig M; Woillard JB
    Eur J Clin Pharmacol; 2020 Jul; 76(7):947-955. PubMed ID: 32358683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses.
    Hehl EM; Beck R; Luthard K; Guthoff R; Drewelow B
    Eur J Clin Pharmacol; 1999 Jun; 55(4):317-23. PubMed ID: 10424326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin and gentamicin concentrations in the serum of normal and anephric patients.
    Lockwood WR; Bower JD
    Antimicrob Agents Chemother; 1973 Jan; 3(1):125-9. PubMed ID: 4790568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.